P2RY12 and Schnyder corneal dystrophy: This strong reduction effect is supported by a highly significant p-value (p < 0.001) and a narrow CI (0.135–0.603), which suggests robust evidence that P2Y12 antagonist use is protective against SCD (Fig 2).